These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2611777)

  • 21. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of cyclodextrins in isotachophoresis. VI. Cyclodextrins as leading electrolyte additives for the separation of bile acids.
    Snopek J; Smolková-Keulemansová E; Jelínek I; Dohnal J; Klinot J; Klinotová E
    J Chromatogr; 1988 Oct; 450(3):373-9. PubMed ID: 3241020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 24. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some properties and the inclusion behavior of branched cyclodextrins.
    Okada Y; Kubota Y; Koizumi K; Hizukuri S; Ohfuji T; Ogata K
    Chem Pharm Bull (Tokyo); 1988 Jun; 36(6):2176-85. PubMed ID: 3240453
    [No Abstract]   [Full Text] [Related]  

  • 26. Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state.
    Smulevich G; Feis A; Mazzi G; Vincieri FF
    J Pharm Sci; 1988 Jun; 77(6):523-6. PubMed ID: 3171933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes.
    Armstrong DW; Ward TJ; Armstrong RD; Beesley TE
    Science; 1986 May; 232(4754):1132-5. PubMed ID: 3704640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of alpha cyclodextrin to eliminate interference by nonesterified fatty acids in calcium measurements.
    Witte DL; Pennell BJ; Pfohl JK; Feld RD
    Am J Clin Pathol; 1981 Jul; 76(1):86-8. PubMed ID: 7258156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
    Han SM; Atkinson WM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
    Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
    Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution of substituents in 2-hydroxypropyl ethers of cyclomaltoheptaose.
    Pitha J; Rao CT; Lindberg B; Seffers P
    Carbohydr Res; 1990 Apr; 200():429-35. PubMed ID: 2379216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic study of beta-cyclodextrin-dye system by high-pressure temperature-jump method.
    Nakatani H; Hiromi K
    J Biochem; 1984 Jul; 96(1):69-72. PubMed ID: 6490608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the occurrence of three-center hydrogen bonds in cyclodextrins in crystalline form and in aqueous solution: comparison of neutron diffraction and molecular dynamics results.
    Koehler JE; Saenger W; van Gunsteren WF
    J Biomol Struct Dyn; 1988 Aug; 6(1):181-98. PubMed ID: 3271518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation].
    Hibi T; Tatsumi M; Hanabusa M; Higuchi R; Imai T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1984 Sep; 104(9):990-6. PubMed ID: 6335527
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Yamasaki M; Seo H; Hashimoto T; Tsuruoka M
    J Pharm Sci; 1983 Nov; 72(11):1338-41. PubMed ID: 6644599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling of beta-cyclodextrin drug inclusion complexes based on NMR-interaction measurements.
    Wiese M; Backensfeld T; Chi H; Müller B; Seydel JK
    Prog Clin Biol Res; 1989; 291():233-6. PubMed ID: 2726853
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.